Market Report, "Puerto Rico Pharmaceuticals & Healthcare Report Q2 2013", Published
The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will continue to deteriorate due to drug patent expiration, production quality issues, increasing labour and other operational costs, and the potential tax increase from the local government.
View full press release